Evidence map›Paper›PMID 34607573›Full record

ArticleBMC bioinformatics2021

Practical identifiability in the frame of nonlinear mixed effects models: the example of the in vitro erythropoiesis.

Ronan Duchesne, Anissa Guillemin, Olivier Gandrillon, Fabien Crauste

Abstract read
In one paragraph

Article in BMC bioinformatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ronan DuchesneLaboratory of Biology and Modeling of the Cell, CNRS UMR 5239, INSERM U1210, Université de Lyon, ENS de Lyon, Université Claude Bernard Lyon 1, 46 allée d'Italie, 69007, Lyon, France. ronan.duchesne@ens-lyon.fr.
Anissa GuilleminLaboratory of Biology and Modeling of the Cell, CNRS UMR 5239, INSERM U1210, Université de Lyon, ENS de Lyon, Université Claude Bernard Lyon 1, 46 allée d'Italie, 69007, Lyon, France.
Olivier GandrillonLaboratory of Biology and Modeling of the Cell, CNRS UMR 5239, INSERM U1210, Université de Lyon, ENS de Lyon, Université Claude Bernard Lyon 1, 46 allée d'Italie, 69007, Lyon, France.
Fabien CrausteCNRS, MAP5 UMR 8145, Université de Paris, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNonlinear mixed effects models provide a way to mathematically describe experimental data involving a lot of inter-individual heterogeneity. In order to assess their practical identifiability and estimate confidence intervals for their parameters, most mixed effects modelling programs use the Fisher Information Matrix. However, in complex nonlinear models, this approach can mask practical unidentifiabilities.

resultsHerein we rather propose a multistart approach, and use it to simplify our model by reducing the number of its parameters, in order to make it identifiable. Our model describes several cell populations involved in the in vitro differentiation of chicken erythroid progenitors grown in the same environment. Inter-individual variability observed in cell population counts is explained by variations of the differentiation and proliferation rates between replicates of the experiment. Alternatively, we test a model with varying initial condition.

conclusionsWe conclude by relating experimental variability to precise and identifiable variations between the replicates of the experiment of some model parameters.

Indexed as

AlgorithmsErythropoiesisModels, BiologicalNonlinear DynamicsReading FramesModel reductionNonlinear mixed effects modelsPractical identifiability

Identifiers

PMID34607573
PMCPMC8489053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.